Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
875 Leser
Artikel bewerten:
(2)

Dental Bone Graft Substitute Market worth $2.04 billion by 2031 | MarketsandMarkets

DELRAY BEACH, Fla., Feb. 10, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Dental Bone Graft Substitute Market is projected to grow from about USD 1.40 billion in 2026 to USD 2.04 billion by 2031, at a CAGR of 6.5%.

MarketsandMarkets Logo

Browse 250 market data Tables and 50 Figures spread through 300 Pages and in-depth TOC on "Dental Bone Graft Substitutes Market - Global Forecast to 2031"

Dental Bone Graft Substitute Market Size & Forecast:

  • Market Size Available for Years: 2025-2031
  • 2026 Market Size: USD 1.40 billion
  • 2031 Projected Market Size: USD 2.04 billion
  • CAGR (2026-2031): 6.5 %

Dental Bone Graft Substitute Market Trends & Insights:

  • The xenografts segment accounted for the largest share of the dental bone graft substitutes market in 2025.
  • The Bio OSS segment accounted for the largest share of 26.7% of the dental bone graft substitutes market in 2025.
  • North America accounted for the largest share of 40.0% of the dental bone graft substitutes market in 2025.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159678690

The dental bone graft substitutes market has undergone significant changes, driven by a combination of animal and human bones and chemically synthesized materials, which now dominate the industry. The increasing prevalence of tooth loss, periodontal disease, and maxillofacial defects has driven a heightened demand for effective bone regeneration solutions. Additionally, both patients and clinicians are becoming increasingly aware of advanced dental restoration options, leading to a growing use of dental implants.

Technological innovations have paved the way for the development of various graft materials, including xenografts, allografts, and synthetic substitutes, which have contributed to improved clinical outcomes and increased popularity of these products. Furthermore, the global demand for bone graft substitutes is being fueled by an aging population, the rise of dental tourism, and a growing focus on oral aesthetics and functional restoration, thereby gradually expanding the market.

By mechanism, the osteoconduction segment accounted for the largest share of the dental bone graft substitutes market in 2024.

The osteoconduction segment plays a significant role in the dental bone graft substitutes market, as it is essential for effective osseous regeneration. This process is critical for providing a supporting structure that allows bone cells to attach and grow. Therefore, these materials are particularly useful in various dental procedures, including dental implants, sinus lifts, and the treatment of periodontal diseases and defects. Commonly used bone grafting agents, such as xenografts, allografts, and synthetic materials, are primarily osteoconductive. Consequently, their sales have a substantial impact on the market for dental and bone graft substitutes. These materials are often preferred clinically for their predictable outcomes and lower biological risks compared to other osseous linkages, such as osteogenesis and osteoinduction.

Request Sample Pages@https://www.marketsandmarkets.com/requestsampleNew.asp?id=159678690

By end user, the hospitals segment accounted for the largest share of the dental bone graft substitutes market in 2024.

Among the various end-user segments of the dental bone graft substitutes market, hospitals are the most dominant. This is primarily due to their robust clinical infrastructure, high patient turnover, and capability to perform a wide range of complex dental and oral procedures. Hospitals frequently handle cases that require bone grafts, such as dental implant surgeries, periodontal treatments, and reconstructive interventions that utilize advanced graft materials. Additionally, hospitals typically have specialized units for dental and maxillofacial surgeries staffed with experienced surgeons and well-trained personnel. This enables them to use bone graft substitutes more effectively than smaller clinics or individual practices. The significant demand for dental bone graft substitutes in hospitals stems from their status as leading performers of these procedures, their technical expertise, and their access to advanced surgical instruments.

Inquire Before Buying@https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=159678690

Top Companies in Dental Bone Graft Substitute Market:

The Top Companies in Dental Bone Graft Substitute Market include Dentsply Sirona (US), Envista (US), Johnson & Johnson (US), Institut Straumann AG (Switzerland), Medtronic (Ireland), Zimvie Inc. (US), Henry Schein Inc. (US), RTI Surgical (US), and LifeNet Health (US), among other players.

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Related Reports:

Dental Implants and Prosthetics Market - Global Forecast to 2030

Dental Equipment Market - Global Forecast to 2031

Dental 3D Printing Market - Global Forecast to 2030

Digital Denture Market - Global Forecast to 2031

Dental Imaging Market - Global Forecast to 2030

About MarketsandMarkets

MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/dental-bone-graft-substitute-market-worth-2-04-billion-by-2031--marketsandmarkets-302683433.html

© 2026 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.